Index -
P/E -
EPS (ttm) -4.54
Insider Own 44.58%
Shs Outstand 14.57M
Perf Week 3.85%
Market Cap 29.77M
Forward P/E -
EPS next Y -1.25
Insider Trans -0.99%
Shs Float 12.22M
Perf Month 49.17%
Income -59.05M
PEG -
EPS next Q -0.43
Inst Own 20.95%
Short Float 3.47%
Perf Quarter 42.11%
Sales 12.17M
P/S 2.45
EPS this Y 62.83%
Inst Trans -
Short Ratio 5.48
Perf Half Y -69.73%
Book/sh -1.18
P/B -
EPS next Y 25.69%
ROA -144.52%
Short Interest 0.42M
Perf Year -82.55%
Cash/sh 0.71
P/C 1.89
EPS next 5Y 30.00%
ROE -
52W Range 0.73 - 9.00
Perf YTD -65.56%
Dividend Est. -
P/FCF -
EPS past 5Y 21.16%
ROI -480.73%
52W High -85.00%
Beta 0.59
Dividend TTM -
Quick Ratio 1.29
Sales past 5Y 18.48%
Gross Margin 28.32%
52W Low 84.93%
ATR (14) 0.12
Dividend Ex-Date -
Current Ratio 1.50
EPS Y/Y TTM 39.13%
Oper. Margin -395.47%
RSI (14) 62.58
Volatility 9.88% 12.86%
Employees 134
Debt/Eq -
Sales Y/Y TTM -3.47%
Profit Margin -485.31%
Recom 2.00
Target Price 1.00
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 56.66%
Payout -
Rel Volume 1.94
Prev Close 1.34
Sales Surprise -8.00%
EPS Surprise -49.33%
Sales Q/Q 3.88%
Earnings May 08 AMC
Avg Volume 77.47K
Price 1.35
SMA20 11.70%
SMA50 32.81%
SMA200 -56.88%
Trades
Volume 150,330
Change 0.75%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-09-22 Downgrade
Craig Hallum
Buy → Hold
$5
Oct-08-20 Initiated
BTIG Research
Neutral
Aug-07-20 Upgrade
Craig Hallum
Hold → Buy
$20
Sep-27-19 Downgrade
JP Morgan
Neutral → Underweight
$16
Nov-07-18 Downgrade
JP Morgan
Overweight → Neutral
May-24-18 Initiated
Craig Hallum
Hold
$25
Dec-13-17 Downgrade
BTIG Research
Buy → Neutral
Jul-12-17 Resumed
BTIG Research
Buy
$34
Mar-24-16 Initiated
JP Morgan
Overweight
$17
Dec-16-15 Initiated
Piper Jaffray
Overweight
May-09-24 12:28PM
06:04AM
(Thomson Reuters StreetEvents)
03:43AM
May-08-24 09:57PM
06:25PM
05:22PM
Loading…
05:22PM
(Associated Press Finance)
04:42PM
May-02-24 10:01AM
09:30AM
Apr-02-24 10:51AM
Mar-29-24 05:57AM
(Thomson Reuters StreetEvents)
Mar-28-24 09:53PM
05:45PM
04:05PM
Mar-07-24 09:30AM
09:20AM
Loading…
Jan-19-24 09:20AM
Jan-16-24 07:45AM
Jan-07-24 08:00PM
Nov-29-23 08:43AM
Nov-27-23 09:15AM
Nov-22-23 09:35AM
Nov-11-23 10:44AM
Nov-09-23 06:42PM
(Associated Press Finance)
04:05PM
Oct-30-23 09:30AM
Oct-03-23 08:50AM
Sep-14-23 11:01PM
Aug-11-23 05:59AM
(Thomson Reuters StreetEvents)
Aug-10-23 05:30PM
04:26PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Jul-27-23 09:30AM
Jul-10-23 09:00AM
Jun-29-23 09:40AM
Jun-13-23 09:40AM
09:00AM
07:03AM
May-23-23 09:40AM
May-12-23 09:53AM
(Thomson Reuters StreetEvents)
May-11-23 05:25PM
04:20PM
04:05PM
09:09AM
May-10-23 11:18AM
10:23AM
09:23AM
Apr-27-23 09:30AM
Apr-19-23 08:38AM
Apr-17-23 06:38AM
(Simply Wall St.) +13.64%
Apr-03-23 12:00PM
Apr-01-23 12:47PM
Mar-29-23 05:25PM
04:05PM
Mar-15-23 09:30AM
Mar-14-23 08:00PM
Mar-08-23 08:30AM
Feb-06-23 05:23AM
Dec-19-22 01:32PM
Nov-16-22 10:22AM
Nov-14-22 04:05PM
Oct-24-22 01:52PM
10:02AM
Oct-19-22 01:27PM
Aug-23-22 08:02AM
(Simply Wall St.) +12.59%
Aug-19-22 04:50PM
(American City Business Journals) -49.40%
Aug-18-22 09:30PM
09:28AM
Aug-17-22 06:00PM
Aug-15-22 02:41PM
08:15AM
06:50AM
Jul-28-22 07:09AM
Jul-25-22 09:30AM
Jul-11-22 08:00AM
Jun-13-22 06:55AM
May-23-22 09:30AM
May-16-22 06:15PM
04:05PM
08:06AM
May-12-22 06:25PM
May-10-22 05:55PM
May-05-22 09:00AM
May-04-22 08:25AM
Apr-29-22 09:30AM
Apr-25-22 08:41AM
Mar-28-22 08:05AM
Mar-15-22 06:15AM
Mar-08-22 05:45PM
04:05PM
Feb-24-22 09:30AM
Feb-15-22 03:01PM
Feb-10-22 05:55PM
Feb-02-22 09:30AM
Jan-31-22 05:05AM
(Simply Wall St.) +17.67%
Jan-28-22 09:38AM
Jan-13-22 09:15AM
Jan-12-22 09:15AM
Dec-29-21 09:30AM
Dec-01-21 04:07AM
Nov-27-21 06:35AM
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BURRIS WAYNE Director May 31 '24 Option Exercise 0.00 839 0 1,678 Jun 03 05:06 PM SCHULER JACK W Director May 29 '24 Option Exercise 0.00 7,894 0 15,488 May 30 04:25 PM Regan Jennifer Director May 29 '24 Option Exercise 0.00 12,631 0 12,631 May 30 04:25 PM FRANCESCONI LOUISE Director May 29 '24 Option Exercise 0.00 7,894 0 28,821 May 30 04:25 PM MASSARANY HANY Director May 29 '24 Option Exercise 0.00 7,894 0 32,154 May 30 04:16 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Option Exercise 0.00 1,283 0 82,114 May 21 07:03 PM Mertz Larry Michael Chief Technology Officer May 20 '24 Sale 0.88 361 318 81,831 May 21 07:03 PM Phillips Jack Chief Executive Officer Apr 17 '24 Option Exercise 0.00 59,928 0 189,654 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 17 '24 Sale 0.78 26,735 20,853 162,919 Apr 18 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Option Exercise 0.00 59,928 0 156,271 Apr 16 04:10 PM Phillips Jack Chief Executive Officer Apr 12 '24 Sale 0.86 26,545 22,829 129,726 Apr 16 04:10 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Option Exercise 0.00 40,633 0 95,090 Apr 10 05:26 PM Patience David Chief Financial Officer Apr 09 '24 Option Exercise 0.00 37,468 0 63,715 Apr 10 05:27 PM Mertz Larry Michael Chief Technology Officer Apr 09 '24 Sale 0.87 13,984 12,166 81,106 Apr 10 05:26 PM Patience David Chief Financial Officer Apr 09 '24 Sale 0.87 13,296 11,568 50,419 Apr 10 05:27 PM Phillips Jack Chief Executive Officer Apr 04 '24 Option Exercise 0.00 35,523 0 112,230 Apr 05 04:26 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Option Exercise 0.00 2,866 0 55,435 Apr 05 04:29 PM Phillips Jack Chief Executive Officer Apr 04 '24 Sale 0.88 15,887 13,981 96,343 Apr 05 04:26 PM Mertz Larry Michael Chief Technology Officer Apr 04 '24 Sale 0.88 978 861 54,457 Apr 05 04:29 PM Patience David Chief Financial Officer Feb 26 '24 Option Exercise 0.00 1,000 0 26,597 Feb 27 06:59 PM Patience David Chief Financial Officer Feb 26 '24 Sale 0.96 350 336 26,247 Feb 27 06:59 PM Phillips Jack Chief Executive Officer Feb 01 '24 Option Exercise 0.00 1,000 0 77,201 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Feb 01 '24 Sale 1.30 494 642 76,707 Feb 02 04:48 PM Phillips Jack Chief Executive Officer Dec 13 '23 Option Exercise 0.00 1,721 0 60,274 Dec 14 05:15 PM Patience David Chief Financial Officer Dec 13 '23 Option Exercise 0.00 331 0 9,028 Dec 14 05:14 PM Phillips Jack Chief Executive Officer Dec 13 '23 Sale 4.39 739 3,244 59,535 Dec 14 05:15 PM Patience David Chief Financial Officer Dec 13 '23 Sale 4.39 97 426 8,931 Dec 14 05:14 PM Phillips Jack Chief Executive Officer Oct 13 '23 Option Exercise 0.00 1,721 0 58,310 Oct 16 05:16 PM Patience David Chief Financial Officer Oct 13 '23 Option Exercise 0.00 331 0 8,559 Oct 16 05:17 PM Phillips Jack Chief Executive Officer Oct 13 '23 Sale 5.83 734 4,279 57,576 Oct 16 05:16 PM Patience David Chief Financial Officer Oct 13 '23 Sale 5.83 96 560 8,463 Oct 16 05:17 PM Patience David Chief Financial Officer Sep 13 '23 Option Exercise 0.00 331 0 8,324 Sep 14 04:11 PM Phillips Jack Chief Executive Officer Sep 13 '23 Option Exercise 0.00 1,722 0 57,322 Sep 14 04:13 PM Phillips Jack Chief Executive Officer Sep 13 '23 Sale 6.53 733 4,786 56,589 Sep 14 04:13 PM Patience David Chief Financial Officer Sep 13 '23 Sale 6.53 96 627 8,228 Sep 14 04:11 PM Phillips Jack Chief Executive Officer Aug 14 '23 Sale 6.80 751 5,107 55,600 Aug 15 07:22 PM Patience David Chief Financial Officer Aug 14 '23 Sale 6.80 95 646 7,993 Aug 15 07:22 PM Phillips Jack Chief Executive Officer Aug 13 '23 Option Exercise 0.00 1,722 0 56,351 Aug 15 07:22 PM Patience David Chief Financial Officer Aug 13 '23 Option Exercise 0.00 331 0 8,088 Aug 15 07:22 PM Phillips Jack Chief Executive Officer Jul 13 '23 Option Exercise 0.00 1,722 0 55,358 Jul 17 05:11 PM Patience David Chief Financial Officer Jul 13 '23 Option Exercise 0.00 330 0 7,849 Jul 17 05:20 PM Phillips Jack Chief Executive Officer Jul 13 '23 Sale 6.90 729 5,030 54,629 Jul 17 05:11 PM Patience David Chief Financial Officer Jul 13 '23 Sale 6.90 92 635 7,757 Jul 17 05:20 PM Phillips Jack Chief Executive Officer Jun 22 '23 Option Exercise 0.00 62,160 0 563,624 Jun 26 06:48 PM Phillips Jack Chief Executive Officer Jun 22 '23 Sale 0.71 27,262 19,356 536,362 Jun 26 06:48 PM
Index -
P/E -
EPS (ttm) -0.55
Insider Own 63.08%
Shs Outstand 96.24M
Perf Week 20.30%
Market Cap 183.50M
Forward P/E -
EPS next Y -0.26
Insider Trans -0.16%
Shs Float 42.35M
Perf Month 4.92%
Income -47.06M
PEG -
EPS next Q -0.09
Inst Own 17.57%
Short Float 0.54%
Perf Quarter 8.84%
Sales 54.85M
P/S 3.35
EPS this Y 43.06%
Inst Trans 15.77%
Short Ratio 1.56
Perf Half Y 1.27%
Book/sh -0.06
P/B -
EPS next Y 27.37%
ROA -56.02%
Short Interest 0.23M
Perf Year 9.59%
Cash/sh 0.10
P/C 15.83
EPS next 5Y -
ROE -414.09%
52W Range 1.03 - 2.21
Perf YTD -13.04%
Dividend Est. -
P/FCF -
EPS past 5Y 8.42%
ROI -85.01%
52W High -27.60%
Beta 1.21
Dividend TTM -
Quick Ratio 0.87
Sales past 5Y 24.79%
Gross Margin 76.27%
52W Low 55.34%
ATR (14) 0.11
Dividend Ex-Date -
Current Ratio 0.91
EPS Y/Y TTM 59.03%
Oper. Margin -65.45%
RSI (14) 62.57
Volatility 7.58% 7.17%
Employees 217
Debt/Eq -
Sales Y/Y TTM 34.69%
Profit Margin -85.80%
Recom 1.00
Target Price 3.10
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 41.75%
Payout -
Rel Volume 2.03
Prev Close 1.58
Sales Surprise 4.49%
EPS Surprise 1.48%
Sales Q/Q 63.63%
Earnings May 08 AMC
Avg Volume 145.50K
Price 1.60
SMA20 10.44%
SMA50 15.09%
SMA200 2.89%
Trades
Volume 294,913
Change 1.27%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-24 Initiated
TD Cowen
Buy
$2.80
May-03-24 Initiated
Lake Street
Buy
$3
Nov-17-21 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$21 → $11
Nov-23-20 Initiated
William Blair
Outperform
Nov-23-20 Initiated
Morgan Stanley
Overweight
$20
Nov-23-20 Initiated
Canaccord Genuity
Buy
$26
Nov-23-20 Initiated
BTIG Research
Buy
$22
May-28-24 06:00AM
May-21-24 06:00AM
May-10-24 05:59PM
03:55PM
May-09-24 03:46AM
09:00PM
Loading…
May-08-24 09:00PM
05:20PM
04:01PM
May-07-24 06:00AM
Apr-24-24 06:00AM
Apr-09-24 05:00PM
Apr-05-24 07:17AM
Mar-25-24 06:00AM
Mar-04-24 09:04AM
Mar-01-24 10:40PM
(Thomson Reuters StreetEvents)
06:31AM
Loading…
06:31AM
06:00AM
Feb-26-24 06:00AM
Feb-16-24 06:00AM
Feb-13-24 03:00AM
Jan-26-24 09:04AM
Nov-14-23 06:00AM
Nov-09-23 06:00AM
Nov-07-23 04:01PM
Oct-24-23 06:00AM
Oct-03-23 06:00AM
Sep-07-23 06:00AM
Sep-05-23 06:00AM
Aug-22-23 06:00AM
Aug-09-23 10:25AM
08:38AM
Loading…
Aug-08-23 08:38AM
(Thomson Reuters StreetEvents)
Aug-07-23 05:15PM
04:01PM
Aug-01-23 06:00AM
Jul-26-23 07:58AM
Jul-24-23 06:00AM
Jul-12-23 06:00AM
Jul-06-23 09:11AM
Jun-27-23 06:00AM
Jun-01-23 06:00AM
May-31-23 06:00AM
May-28-23 08:09AM
May-25-23 06:00AM
May-24-23 06:00AM
May-18-23 07:00AM
May-12-23 11:10AM
(Thomson Reuters StreetEvents) -12.28%
May-11-23 05:25PM
04:01PM
May-09-23 06:15PM
Apr-27-23 06:00AM
Apr-12-23 06:53AM
Mar-15-23 09:31AM
(Simply Wall St.) +15.24%
Mar-08-23 07:14AM
Mar-06-23 07:25AM
06:00AM
Feb-28-23 06:00AM
Feb-21-23 06:00AM
Feb-16-23 06:27AM
Dec-19-22 06:00AM
Dec-16-22 04:01PM
Dec-12-22 06:00AM
Nov-21-22 04:01PM
Nov-17-22 12:26AM
Nov-16-22 04:05PM
04:01PM
Nov-10-22 09:00AM
Nov-09-22 05:33AM
Nov-03-22 07:15AM
06:00AM
Oct-20-22 06:00AM
Oct-17-22 05:05PM
(American City Business Journals)
06:00AM
Oct-12-22 06:00AM
Oct-11-22 06:00AM
Sep-06-22 06:00AM
Aug-09-22 06:00AM
Aug-06-22 04:30AM
Aug-04-22 07:15AM
06:00AM
Aug-03-22 06:00AM
Jul-30-22 10:44AM
Jul-20-22 06:00AM
Jul-19-22 06:00AM
Jun-22-22 09:19AM
Jun-15-22 10:11AM
Jun-07-22 06:00AM
Jun-03-22 06:00AM
Jun-01-22 06:00AM
May-17-22 06:00AM
May-12-22 06:00AM
May-11-22 07:15AM
06:00AM
Apr-27-22 06:00AM
Apr-12-22 08:58AM
Apr-11-22 06:00AM
Mar-29-22 06:00AM
Mar-19-22 09:19AM
Mar-15-22 10:00AM
Mar-14-22 07:15AM
06:00AM
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It also offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Boulder, CO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cowie Robin Harper CFO, Sec'y & Treasurer May 21 '24 Option Exercise 0.42 4,209 1,768 175,889 May 23 07:13 PM Hutton Scott President & CEO May 09 '24 Sale 1.48 3,764 5,569 483,780 May 10 05:04 PM Cowie Robin Harper CFO, Sec'y & Treasurer May 09 '24 Sale 1.48 980 1,450 171,680 May 10 05:04 PM O'Kane Kieran Chief Commercial Officer May 09 '24 Sale 1.48 468 692 75,524 May 10 05:05 PM Pestano Gary Anthony Chief Development Officer May 09 '24 Sale 1.48 434 642 124,248 May 10 05:06 PM Vazquez Chris Chief Accounting Officer May 09 '24 Sale 1.48 244 361 9,915 May 10 05:06 PM Hutton Scott President & CEO Feb 12 '24 Sale 1.66 29,708 49,455 465,011 Feb 12 09:45 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 12 '24 Sale 1.66 8,699 14,481 169,410 Feb 12 09:44 PM O'Kane Kieran Chief Commercial Officer Feb 12 '24 Sale 1.66 5,412 9,009 68,005 Feb 12 09:45 PM Pestano Gary Anthony Chief Development Officer Feb 12 '24 Sale 1.66 5,022 8,360 123,250 Feb 12 09:45 PM Vazquez Chris Chief Accounting Officer Feb 12 '24 Sale 1.66 922 1,535 9,548 Feb 12 09:46 PM Hutton Scott President & CEO Feb 09 '24 Sale 1.92 34,682 66,472 494,719 Feb 12 09:45 PM Cowie Robin Harper CFO, Sec'y & Treasurer Feb 09 '24 Sale 1.92 10,156 19,465 178,109 Feb 12 09:44 PM O'Kane Kieran Chief Commercial Officer Feb 09 '24 Sale 1.92 6,319 12,111 73,417 Feb 12 09:45 PM Pestano Gary Anthony Chief Development Officer Feb 09 '24 Sale 1.92 5,862 11,235 128,272 Feb 12 09:45 PM Vazquez Chris Chief Accounting Officer Feb 09 '24 Sale 1.92 1,077 2,064 10,470 Feb 12 09:46 PM Hutton Scott President & CEO Nov 10 '23 Sale 1.23 1,883 2,308 329,428 Nov 13 04:50 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 10 '23 Sale 1.23 491 602 136,573 Nov 13 04:50 PM O'Kane Kieran Chief Commercial Officer Nov 10 '23 Sale 1.23 235 288 47,712 Nov 13 04:50 PM Pestano Gary Anthony Chief Development Officer Nov 10 '23 Sale 1.23 218 267 104,501 Nov 13 04:51 PM Vazquez Chris Chief Accounting Officer Nov 10 '23 Sale 1.23 108 132 6,251 Nov 13 04:51 PM Hutton Scott President & CEO Nov 09 '23 Sale 1.27 1,882 2,391 331,311 Nov 13 04:50 PM Cowie Robin Harper CFO, Sec'y & Treasurer Nov 09 '23 Sale 1.27 491 624 137,064 Nov 13 04:50 PM O'Kane Kieran Chief Commercial Officer Nov 09 '23 Sale 1.27 234 297 47,947 Nov 13 04:50 PM Pestano Gary Anthony Chief Development Officer Nov 09 '23 Sale 1.27 217 276 104,719 Nov 13 04:51 PM Vazquez Chris Chief Accounting Officer Nov 09 '23 Sale 1.27 107 136 6,359 Nov 13 04:51 PM SCHULER JACK W Director Aug 23 '23 Buy 1.71 87,500 149,240 30,707,722 Aug 23 06:56 PM SCHULER JACK W Director Aug 22 '23 Buy 1.67 8,307 13,859 30,620,222 Aug 23 06:56 PM SCHULER JACK W Director Aug 21 '23 Buy 1.64 32,556 53,411 30,611,915 Aug 23 06:56 PM Hutton Scott President & CEO Aug 10 '23 Sale 1.27 6,889 8,728 318,013 Aug 10 07:28 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 10 '23 Sale 1.27 1,788 2,265 131,535 Aug 10 07:27 PM O'Kane Kieran Chief Commercial Officer Aug 10 '23 Sale 1.27 849 1,076 46,692 Aug 10 07:28 PM Pestano Gary Anthony Chief Development Officer Aug 10 '23 Sale 1.27 786 996 103,558 Aug 10 07:29 PM Vazquez Chris Chief Accounting Officer Aug 10 '23 Sale 1.27 279 353 5,865 Aug 10 07:30 PM Hutton Scott President & CEO Aug 09 '23 Sale 1.39 6,893 9,570 324,902 Aug 10 07:28 PM Cowie Robin Harper CFO, Sec'y & Treasurer Aug 09 '23 Sale 1.39 1,789 2,484 133,323 Aug 10 07:27 PM O'Kane Kieran Chief Commercial Officer Aug 09 '23 Sale 1.39 850 1,180 47,541 Aug 10 07:28 PM Pestano Gary Anthony Chief Development Officer Aug 09 '23 Sale 1.39 787 1,093 104,344 Aug 10 07:29 PM Vazquez Chris Chief Accounting Officer Aug 09 '23 Sale 1.39 280 389 6,144 Aug 10 07:30 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite